Cota expands Novartis agreement
NEW YORK — Cota Healthcare inked a multi-year collaboration agreement with Novartis to help improve clinical and cost outcomes for breast cancer patients.
As part of this agreement, which expands significantly on the previous announced collaboration entered into January 2016, teams from across Novartis will leverage Cota's research-grade, real-world evidence, web-based analysis and visualization tools, and be supported by Cota's medical, data science, and technology experts. Utilizing the real-world evidence and technology platform supplied by Cota, it states it is expected to enable Novartis to accelerate clinical development of new therapies for breast cancer and identify which patients will benefit most.
"Data and insight that comes directly from patient records — real-world evidence — is transforming how pharmaceutical and life science companies develop more precise, targeted therapies," said John Hervey, CEO of Cota. "Novartis has been an incredible collaborator over the last several years in adopting Cota's real-world evidence solutions to advance our shared goal of quantifiably improving and extending patient lives."
Cota, a data and technology platform for value-based precision medicine, is powered by the patented Cota Nodal Address system, a digital classification methodology that stratifies patients based on all the personal and clinical factors that matter to the individual.
"We're excited about helping Novartis get deep insight into how patients are getting treatment in practice and connecting the dots all the way from patient to doctor to researcher," said Dr. Andrew Pecora, Founder and Executive Chairman of Cota. "Analyzing this data using CNAs is a critical factor in enabling healthcare companies to develop and target therapies that increase outcomes and lower the total cost of care."
The Exchange generates $8.3 billion, dispurses $224 million in dividends
DALLAS — The Exchange on Friday released a video touting the military retailer's fiscal 2017 financials. The Exchange raised $8.3 billion in revenue, a decline of 2.4% compared to the year-ago period, while earnings were down 3.5% to $388 million.
The Exchange dispursed $224 million in dividends in the last year, which supports the military and their families. In the past 10 years, the Exchange has distributed more than $2.4 billion to fund quality-of-life improvements. The Exchange retains one-third of annual earnings to construct new stores, modernize regional distribution centers and upgrade its worldwide network to operate retail stores.
Toward that end, the Exchange funded 43 facility improvements and new store openings over the past year, including the Exchange's newest distribution center at Germersheim Army Depot in Germany on Feb. 1, 2017. The distribution center ships beverages, boxed food, appliances and more to Exchange main stores and Express locations throughout Europe, Southwest Asia and contingency locations.
Currently, 85% of Exchange employees are connected to the military family.